comparemela.com

Sandro Krieg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Quantifying the risk of surgery‐related aphasia after brain tumor removal

Can surgeons quantify the risk of aphasia when removing a brain tumor? To find out, researchers at Klinikum rechts der Isar of the Technical University of Munich (TUM) are analyzing the brain as a network. In a current study with 60 patients, they already achieved an accuracy rate with three quarters of their predictions.

Nexstim Oyj: Impressive New Study Results Suggest Potential New Therapeutic Use for Nexstim SmartFocus nTMS in Postsurgical Rehabilitation of Paresis

Nexstim Oyj: Impressive New Study Results Suggest Potential New Therapeutic Use for Nexstim SmartFocus nTMS in Postsurgical Rehabilitation of Paresis SmartFocus in Postsurgical Rehabilitation of Paresis Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( Nexstim or Company ) announces that a new study published in Brain Stimulation in May reports that the therapeutic use of Nexstim navigated repetitive transcranial magnetic stimulation (nrTMS) significantly improved outcomes for glioma patients suffering from post-surgical paresis. The study suggests that patients who suffer from a severe decline in hand function after brain tumor surgery can be treated post-operatively for 7 days with 15 minutes of nrTMS plus 30 minutes of physiotherapy per day.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.